<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">scbmt</journal-id><journal-title-group><journal-title xml:lang="ru">БИОМЕДИЦИНА</journal-title><trans-title-group xml:lang="en"><trans-title>Journal Biomed</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2074-5982</issn><issn pub-type="epub">2713-0428</issn><publisher><publisher-name>Scientific center of biomedical technologies of Federal Medical and Biological Agency</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">scbmt-705</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Статьи</subject></subj-group></article-categories><title-group><article-title>Приверженность к антиретровирусной терапии
и факторы, ее определяющие
Adherence to antiretroviral therapy
 and the factors that determine it</article-title><trans-title-group xml:lang="en"><trans-title></trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мирошников</surname><given-names>А. Е.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Хохлов</surname><given-names>А. Л.</given-names></name></name-alternatives><email xlink:type="simple">alekskhokhlov@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Байкова</surname><given-names>С. А.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff xml:lang="ru" id="aff-1"><institution>Ярославская государственная медицинская академия, Ярославль</institution><country>Russian Federation</country></aff><pub-date pub-type="collection"><year>2011</year></pub-date><pub-date pub-type="epub"><day>13</day><month>02</month><year>2020</year></pub-date><volume>1</volume><issue>4</issue><fpage>106</fpage><lpage>109</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Мирошников А.Е., Хохлов А.Л., Байкова С.А., 2020</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="ru">Мирошников А.Е., Хохлов А.Л., Байкова С.А.</copyright-holder><copyright-holder xml:lang="en">Мирошников А.Е., Хохлов А.Л., Байкова С.А.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://journal.scbmt.ru/jour/article/view/705">https://journal.scbmt.ru/jour/article/view/705</self-uri><abstract><p>Важным результатом работы является выявление высокой приверженности только у 33,3% паци-
ентов, тогда как низкой - у 34,5% пациентов, что, учитывая высокую способность ВИЧ к мутациям и
развитию резистентности, а также довольно ограниченный арсенал АРВ-препаратов, указывает о не-
благоприятном прогнозе заболевания в группе пациентов с низкой приверженностью.
An important result of the investigation is the identification of a high commitment in 33.3% of patients
only, whereas low - in 34.5% of patients, given that the high ability of HIV to mutation and development
of resistance, as well as a very limited arsenal of antiretroviral drugs, indicates a poor disease prognosis in
patients with low adherence.</p></abstract><kwd-group xml:lang="ru"><kwd>антиретровирусная терапия</kwd><kwd>antiretrovirus therapy</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
